Profile_bird

Hey there! ContractPharma is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What are you doing? Join today to start receiving ContractPharma's tweets.

Already using Twitter
from your phone? Click here.

ContractPharma

  1. Financial Reports: AMRI http://bit.ly/wwnQw
  2. Evotec, BI Extend Research Pact http://bit.ly/3iX3Y9
  3. Althea Adds Formulation Development to Contract Services Slate http://bit.ly/1AVMOl
  4. Quintiles Opens Expanded Asia-Pac HQ http://bit.ly/8oBu0
  5. Gloucester’s Istodax Approved for Cutaneous T-cell Lymphoma http://bit.ly/2KBeOd
  6. Ziopharm Sarcoma Trial Gets Promising Data http://bit.ly/2ltb6i
  7. Ligand, Pfizer Extend JAK3 Research Pact http://bit.ly/3eGazG
  8. Financial Report: Kendle 3Q http://bit.ly/102ryt
  9. Financial Report: Omnicare 3Q http://bit.ly/4haxSd
  10. Phase Forward Signs Multi-Year EDC Agreement with Quotient Clinical http://bit.ly/30t0lp
  11. Vetter Adds U.S. Development Facility http://bit.ly/2pnu54
  12. Toxikon Boosts Biologics Safety Program Services http://bit.ly/2rMrYz
  13. Norwich Expands Services with New Pilot Scale Facility http://bit.ly/4wOOLR
  14. Merged Merck Begins Operations Worldwide http://bit.ly/RfSK7
  15. Executive Moves: Coldstream Laboratories http://bit.ly/1763wG
  16. Emerson, Bio Research Enter Strategic Pact http://bit.ly/1xdu48
  17. J&J To Restructure, Will Fire 7,000 to 8,000 http://bit.ly/1IEEk7
  18. Financial Report: Enzon 3Q http://bit.ly/3aMase
  19. Financial Report: West 3Q http://bit.ly/4g4a3S
  20. Executive Moves: Rosetta Genomics, Ltd. http://bit.ly/3cTHE0